tweetindex
FR

Journal of Clinical Investigation

@jclinicalinvest · Ann Arbor, MI · joined 06 Dec 2010

The JCI is a premiere venue for discoveries in basic & clinical biomedical science. Est. 1924- https://t.co/xG7OGiBMjm Bluesky: https://t.co/2cy2MP5k6A

51 223Followers
3 905Following
9 955Posts total
9.7KViews on collected posts

Derniers posts

Targeting #Ferroptosis in heart and kidney disease: https://t.co/D2HSQBI556 Ferroptosis is a unique form of cell death that has emerged as a central pathway linking metabolic stress and oxidative injury to physiologic and pathologic processes. In this Review, Hossein Ardehali htt
1.5K views · 12 likes · 6 reposts · 1 replies Open on X →
Commentary: Imaging B-Cell Maturation Antigen in Multiple Myeloma: https://t.co/mPftV5ONWG Yangmeihui Song, Wenyu Song, & Weibo Cai discuss Gu et al.: https://t.co/0UXgNd0oC7 #MultipleMyeloma https://t.co/cn90t1WlGT
1.6K views · 7 likes · 3 reposts · 0 replies Open on X →
🧵 BCMA imaging enables a more complete picture of #MultipleMyeloma https://t.co/0UXgNd0oC7 Gu et al. @PKU1898 & @BIT1940 show that a BCMA-targeted PET tracer measures both tumor burden and disease activity in multiple myeloma with superior sensitivity and selectivity to https://
1.5K views · 5 likes · 1 reposts · 1 replies Open on X →
Nominating CARD8 and Caspase-1 as therapeutic targets for patients with Hatipoglu syndrome: https://t.co/lHgROnyi2u Human DPP9 deficiency causes severe pancytopenia that is not recapitulated by conventional Dpp9-/- mice. Here, Tianli Xiao @tianli_xiao et al. @YaleMed have https:
2.7K views · 9 likes · 2 reposts · 1 replies Open on X →
@NeckerInem 🧵 Behind the Scenes: Coauthors (from left to right), Manal Mazloum, Frank Bienaimé, Vicky Scata, & Rushdi Alghamdi working @NeckerInem in Paris, France with one of the TEM microscopes used to demonstrate basement membrane thinning in ADPKD https://t.co/gPXpvhJm2e
381 views · 4 likes · 0 reposts · 1 replies Open on X →
@NeckerInem 🧵 Cilia–to–basement membrane signaling is a biomechanical driver in models of autosomal dominant polycystic kidney disease: https://t.co/37jSxjqF6i https://t.co/H0W2t55D4W
380 views · 2 likes · 2 reposts · 0 replies Open on X →
🧵 Cilia–to–basement membrane signaling initiates cystogenesis in the kidney https://t.co/37jSxjqF6i This issue's cover features work by Mazloum et al. @NeckerInem linking polycystin-1 loss in ADPKD to tubule basement membrane remodeling in a model that implicates both luminal ht
1.7K views · 14 likes · 2 reposts · 1 replies Open on X →

Face aux comptes de taille comparable

7 posts des 90 derniers jours, à côté de la tranche de 10K–100K abonnés. portée ordinaire pour sa taille, réaction plus faible que la moyenne.

Vues médianes1 498ce compte997médiane pour 10K–100K
Portée, %2.92%ce compte3.84%médiane pour 10K–100K
Engagement, %0.98%ce compte1.52%médiane pour 10K–100K
IndicateurCe compteMédiane pour 10K–100KRapport
Vues médianes par post1 4989971.50×
Portée (vues ÷ abonnés)2.92%3.84%0.76×
Taux d'engagement0.98%1.52%0.65×

Autres comptes de cette tranche →   Comparer avec un autre compte →   Comment ces repères sont établis →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

1.7K15 Sep
380
381
2.7K16 Sep
1.5K17 Sep
1.6K
1.5K18 Sep

Last 7 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.98%15 Sep
1.05%
1.31%
0.49%16 Sep
0.47%17 Sep
0.63%
1.34%18 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes63.9%53 in total
Reposts19.3%16 in total
Replies6.0%5 in total
Quotes2.4%2 in total
Bookmarks8.4%7 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Comptes similaires